| pubmed-article:11578753 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11578753 | lifeskim:mentions | umls-concept:C0379900 | lld:lifeskim |
| pubmed-article:11578753 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11578753 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:11578753 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
| pubmed-article:11578753 | lifeskim:mentions | umls-concept:C0053890 | lld:lifeskim |
| pubmed-article:11578753 | lifeskim:mentions | umls-concept:C0380600 | lld:lifeskim |
| pubmed-article:11578753 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11578753 | pubmed:dateCreated | 2001-10-1 | lld:pubmed |
| pubmed-article:11578753 | pubmed:abstractText | Stimulation of central 5-HT(1A) receptors produces bradycardia and diminishes blood pressure in conscious or anesthetized rats. Our objective was to investigate the effects on blood pressure and heart rate of the partial 5-HT(1A) receptor agonist and selective alpha1D-adrenoceptor antagonist BMY 7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-8-azaspiro [4.5] decane-7,9 dione hydrochloride) compared to the full 5-HT(1A) receptor agonist 8-OH-DPAT (8-hydroxy-dipropylamino tetralin) in adult anesthetized rats. | lld:pubmed |
| pubmed-article:11578753 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11578753 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11578753 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11578753 | pubmed:issn | 0188-4409 | lld:pubmed |
| pubmed-article:11578753 | pubmed:author | pubmed-author:Villalobos-Mo... | lld:pubmed |
| pubmed-article:11578753 | pubmed:author | pubmed-author:IbarraMM | lld:pubmed |
| pubmed-article:11578753 | pubmed:author | pubmed-author:López-Guerrer... | lld:pubmed |
| pubmed-article:11578753 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11578753 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:11578753 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11578753 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11578753 | pubmed:pagination | 389-93 | lld:pubmed |
| pubmed-article:11578753 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:meshHeading | pubmed-meshheading:11578753... | lld:pubmed |
| pubmed-article:11578753 | pubmed:articleTitle | The hypotensive effect of BMY 7378 is antagonized by a silent 5-HT(1A) receptor antagonist: comparison with 8-hydroxy-dipropylamino tetralin. | lld:pubmed |
| pubmed-article:11578753 | pubmed:affiliation | Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados (CINVESTAV), Instituto Politécnico Nacional (IPN), Mexico City, Mexico. raffaeld@prodigy.net.mx | lld:pubmed |
| pubmed-article:11578753 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11578753 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11578753 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
